Transcriptomic Signatures Predict Severe Linezolid-Induced Peripheral Neuropathy and Reveal Pre-Treatment Immune and Antioxidant Dysregulation
Transcriptomic profiling of peripheral blood mononuclear cells (PBMCs) from 63 MDR/XDR-TB patients before and after six months of linezolid treatment.